Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: A systematic review. 2022

Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
Univ. Lille, Inserm, CHU Lille, Lille Neurosciences and Cognition, F-59000, Lille, France. Electronic address: qdevignes@gmail.com.

Mild cognitive impairment in Parkinson's disease (PD-MCI) is heterogenous and cognitive subtypes have been identified. However, the anatomo-functional bases of each subtype remain partly unknown. To propose a description of the current literature on neuroimaging findings associated with cognitive subtypes of PD-MCI. PubMed/Medline, Embase, PsycINFO and the Cochrane Library databases were searched (until April 2021). Studies comparing PD-MCI cognitive subtypes with healthy controls (HC) and PD patients with normal cognition (PD-NC) on any neuroimaging outcome were included. Ten studies met the inclusion criteria. Six used structural MRI methods, two functional MRI methods, one electroencephalography and five positron or single-photon emission tomography. Most studies (n = 8) determined PD-MCI subtypes based on memory impairment and two based on executive impairment. Compared with HC and/or PD-NC, brain modifications were found in PD patients (a) with amnestic MCI and, to a lesser extent, non-amnestic MCI in occipital, parietal and temporal regions, (b) with executive MCI in frontal and striatal regions and (c) with non-executive MCI in posterior cortical regions. Very few neuroimaging studies have considered cognitive heterogeneity that exists within PD-MCI, making it difficult to draw robust conclusions regarding brain modifications associated with specific subtypes. Given the promising potential of neuroimaging methods in both clinical practice and research, further studies are needed to overcome the limitations of the current literature.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D059906 Neuroimaging Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities. Brain Imaging,Imaging, Brain
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
January 2022, Frontiers in aging neuroscience,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
January 2020, Current Alzheimer research,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
May 2014, Movement disorders : official journal of the Movement Disorder Society,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
January 2009, Dementia and geriatric cognitive disorders,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
September 2016, Scientific reports,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
August 2012, Movement disorders : official journal of the Movement Disorder Society,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
March 2010, Parkinsonism & related disorders,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
January 2015, Dementia & neuropsychologia,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
December 2021, Clinical neuroradiology,
Quentin Devignes, and Renaud Lopes, and Kathy Dujardin
January 2023, Frontiers in aging neuroscience,
Copied contents to your clipboard!